follow the cohorts , it will be nice if the company can...

follow the cohorts , it will be nice if the company can interview cohort 1 first , then have like a 60min show covering them on channel 9, it will show us the results , really hope it saves lifes and be good investment for us shareholders , very early days , we know its outstanding results for 6 month's with C1(cohort one ) two studies running now ,
terms of revenue ? has it captured any of the market ATM? atm this market is $2-4? b globally? so lets say avr captures 10% of the market, from now on , thats about $300m usa very nice , whats the profit out of that ? $50m ? now whats the revenue as this market grows 25% annually, really big opportunity here ? huge takeover target ? question will AVR do it alone or just get bought out ? what's it worth with the current results? size of the revenue? $2b-$4b all am i completely wrong and this is not as good we think it is ?

big presentation coming in november